LCMS
Další informace
WebinářeO násKontaktujte násPodmínky užití
LabRulez s.r.o. Všechna práva vyhrazena. Obsah dostupný pod licencí CC BY-SA 4.0 Uveďte původ-Zachovejte licenci.
Pořadatel
SelectScience
SelectScience
SelectScience® je inovativní online vydavatel v oboru vědy, který propojuje vědce s informacemi a pomáhá jim při výběru nejlepší laboratoře prostřednictvím kombinace bohatého obsahu, informací typu peer-to-peer a důvěryhodných recenzí produktů
Tagy
LC/MS
OMICS
LinkedIn Logo

Development of a high-throughput lipidomics platform and its application in population-level genetic studies

ZÁZNAM | Proběhlo St, 4.5.2022
Tento webinář popíše vývoj vysoce výkonné cílené LC/MS lipidomické platformy, aplikaci této platformy na studie profilování populace a integraci s genomickými daty.
Přejít na webinář
Pixabay/PixxlTeufel: Development of a high-throughput lipidomics platform and its application in population-level genetic studies
Pixabay/PixxlTeufel: Development of a high-throughput lipidomics platform and its application in population-level genetic studies

This webinar will describe the development of a high-throughput targeted LC/-MS lipidomics platform, the application of this platform to population profiling studies, and the integration with genomic data.

In this webinar, Peter Meikle will address some of the challenges in lipidomics and the opportunities provided by population-level profiling studies. Meikle will further highlight a recent web portal that provides both lipidomic methodologies and tools as well as the lipidomic PheWeb platform.

Key learning objectives

  • Become familiar with lipidomic methodology
  • Understand the genetic analysis of plasma lipid species
  • Understand lipid associations with cardiovascular disease

Who should attend?

  • Lipidomics, metabolomics, genetics, and cardiometabolic disease researchers.

Presenter: Professor Peter J Meikle, Ph.D. (Head, Baker Department of Cardiovascular Research Translation and Implementation, La Trobe University, Baker Heart and Diabetes Institute)

Professor Peter Meikle is Head of the Systems Biology Domain, Co-Lead of the Obesity and Lipids Program, and Head of the Metabolomics Laboratory at the Baker Heart and Diabetes Institute. He is co-Director of the Australian Cardiovascular Alliance, Precision Medicine Flagship, and was recently appointed Head of the Baker Department of Cardiovascular Research, Translation and Implementation at La Trobe University. His research has a focus on the dysregulation of lipid metabolism associated with metabolic diseases, including obesity, diabetes, cardiovascular, and Alzheimer’s disease, and its relationship to the pathogenesis of these disease states. This work is leading to new approaches to early diagnosis and risk assessment, and to the development of new lipid modulating therapies for chronic disease.

Presenter: Moderator: Ellie Abbott (Editorial Team, SelectScience)

Ellie studied biochemistry at the University of Nottingham, UK, and has previous experience working in management consultancy. As a member of the Editorial team, she now plays an integral role in shaping the content on SelectScience.

SelectScience
LinkedIn Logo
 

Mohlo by Vás zajímat

Benefits of Agilent Altura Ultra Inert HPLC Column Hardware

Aplikace
| 2026 | Agilent Technologies
Instrumentace
Spotřební materiál, LC kolony
Výrobce
Agilent Technologies
Zaměření
Životní prostředí

Vinylene carbonate water determination via coulometric Karl Fischer titration

Aplikace
| 2026 | Metrohm
Instrumentace
Titrace Karl Fischer, Voltametrie/Coulometrie
Výrobce
Metrohm
Zaměření
Polovodiče

An Isocratic Separation of B Vitamins Using Waters XBridge Biphenyl RP Column with MaxPeak Premier Technology

Aplikace
| 2026 | Waters
Instrumentace
Spotřební materiál, LC kolony
Výrobce
Waters
Zaměření
Farmaceutická analýza

Impurity Monitoring of GLP-1 Therapeutic Peptide RetatrutideUsing a 2D-LC/TOF System

Postery
| 2026 | Agilent Technologies (ASMS)
Instrumentace
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS, 2D-LC
Výrobce
Agilent Technologies
Zaměření
Farmaceutická analýza

Increased sensitivity for low-input label-free proteomics using the Orbitrap Astral MS and μPAC Neo Plus Columns

Aplikace
| 2026 | Thermo Fisher Scientific
Instrumentace
LC/HRMS, LC/Orbitrap, LC/MS, LC/MS/MS
Výrobce
Thermo Fisher Scientific
Zaměření
Proteomika
Další projekty
GCMS
ICPMS
Sledujte nás
FacebookX (Twitter)LinkedInYouTube
Další informace
WebinářeO násKontaktujte násPodmínky užití
LabRulez s.r.o. Všechna práva vyhrazena. Obsah dostupný pod licencí CC BY-SA 4.0 Uveďte původ-Zachovejte licenci.